ABSTRACT
Objective To investigated the effects of combined arsenic trioxide(ATO) and resveratrol(Res)on the viability of NB4 human leukemia cells. Methods NB4 human leukemia cell was used in this experiment.Cells were cultured in ATO (0,0.1875,0.3750,0.7500, 1.1250, 1.5000,2.2500,3.0000,5.0000 μmol/L) and Res (0, 1.5625,3.1250,6.2500, 12.5000, 18.7500,25.0000,37.5000,50.0000 μmol/L). Cell viabilities were measured by MTT in different treatment groups. Half inhibitory concentration(IC50) was calculated. The ratio of concentration of ATO and Res 1.5∶ 18,1.5∶ 25,1.5∶ 35 was added to cells, and the combination index(CI) was calculated. The level of ROS in control, ATO( 1.5000 μmol/L), Res(25.0000 μmol/L) and ATO(0.9000 μmol/L) + Res( 12.5000μmol/L) groups was measured by chemiluminescence assay. Results ①ATO( ≥0.7500 μmol/L) reduced the viability of NB4 cells in a concentration-dependent manner(P ＜ 0.05 ), and IC50 was (1.78 ± 0.11 )μmol/L. ②)Res (≥18.7500 μ mol/L) dose-dependently decreased the viability of NB4 cells (P ＜ 0.05 ), and IC50 was ( 18.71 ±0.18)μ mol/L. ③Combination of ATO and Res showed an antagonistic effect on NB4 cells viability. ④The ROS in Res group( 1670.55 ± 13.97) was significantly lower than that in control group(2345.88 ± 14.48,P ＜ 0.05). The ROS in ATO group (3092.42 ± 94.84) was significantly higher than that in control group(P ＜ 0.05). The ROS in ATO + Res group (1860.27 ± 15.99) was significantly lower than that in ATO group(P ＜ 0.05). Conclusions NB4 cell survival rate can be decreased by ATO and Res. The combination of arsenic trioxide and Res presents an antagonistic effect on NB4 cell viability, in part by reducing intracellular ROS formation.
ABSTRACT
<p><b>OBJECTIVE</b>To study the effect of exogenous nucleic acid on physical functions, morphology of hepatic cells and brain neurons in aged rats.</p><p><b>METHODS</b>Thirty two aged Wistar rats (20 month-old) were divided randomly into four groups (one aged control group and three aged experimental groups) and eight young rats (3 month-old) was set as young control group. Control groups were fed on standard chow and experimental groups were fed on standard chow supplemented with 93.75 mg/kg (high-dosage group), 46.88 mg/kg (middle-dosage group) and 9.38 mg/kg (low-dosage group) of yeast RNA respectively. SOD, MDA, HDL, sex hormone and growth hormone were determined at the end of a 4-week observation. The microcosmic images of the hepatic cells and brain neurons using the image-pro plus (V.4.0) were also observed.</p><p><b>RESULTS</b>SOD, serum HDL and growth hormone levels in the high dosage group were significantly higher (P < 0.05) than that in the aged control group, and the levels were not different from that in the young control group. MDA level of all yeast RNA supplemented groups was significantly lower than that of aged control group (P < 0.05) and that was not different from the young control group. Serum testosterone of the high and middle dosage groups reached the level of young control group, and that was much higher than the aged control and low dosage group (P < 0.05). Estradiol levels among the aged rats were not different, and those were much lower than the young control group (P < 0.05). Much more number of brain neurons were observed in the high-dose group than other aged rats (P < 0.05). Brain neurons, hepatic cells and karyons in the high-dose group were bigger than that in other aged rats (P < 0.05).</p><p><b>CONCLUSION</b>Exogenous yeast RNA might play an important role in physical functions, the morphology of brain neurons and hepatic cells in natural aged rats. There might have a dose-effect relationship in the process.</p>
Subject(s)
Animals , Male , Rats , Aging , Brain , Physiology , Dose-Response Relationship, Drug , Hepatocytes , Liver , Physiology , Neurons , RNA, Fungal , Pharmacology , Random Allocation , Rats, Wistar , Yeasts , ChemistryABSTRACT
<p><b>OBJECTIVE</b>To investigate the effect and its mechanism of salmon milt DNA (SMD) on age-related involutions in mouse thymus.</p><p><b>METHODS</b>Female BALB/C mice aged 10 months were divided randomly into three groups according to their weights. They were high dosage group (333.33 mg.kg(-1).b.w.d(-1)), low dosage group (166.67 mg.kg(-1).b.w.d(-1)) and control group (0 mg.kg(-1).b.w.d(-1)). After five weeks, their thymus indexes were measured and the thymocytes were counted and the thymus cortex thicknesses were also measured using Image-Pro Plus (version. 4.0) software in the thymus section. All the data were analyzed by SAS statistic software. Microarray technique was applied to screen the gene fragments, which were differentially expressed between the high dosage group and the control group, together with RT-PCR to further confirm some of them.</p><p><b>RESULTS</b>No significant differences of the variables including body weight, thymus weight and thymus indexes among the three groups were found. The thymocytes quantities of thymus cortex and medulla in the high dosage group were significantly higher than those of the control group (P < 0.01 and P < 0.05, respectively). The thymus cortex thicknesses of both SMD supplement groups were significantly higher than that of the control group (P < 0.01 and P < 0.05 respectively). 112 differently expressed gene fragments were isolated. Furthermore, we found the fragments with the logged number of U23789, X80232 and Aw209102 were highly expressed in the high dosage group when RT-PCR technique was used.</p><p><b>CONCLUSIONS</b>SMD may reverse the age-related involutions in mouse thymus via up-regulation the expression of proliferation related genes and via up-regulation the expression of development and differentiation related genes simultaneously.</p>